Skip to main content
Mina Chung, MD, Cardiology, Cleveland, OH

MinaKChungMD

Cardiology Cleveland, OH

Adult Congenital Heart Disease, Cardiac Electrophysiology

Staff, Cleveland Clinic; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine

Dr. Chung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chung's full profile

Already have an account?

  • Office

    9500 Euclid Ave
    J2-2
    Cleveland, OH 44195
    Phone+1 216-444-2290

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1991 - 1993
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1990 - 1991
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1986 - 1990
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1983 - 1986
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1983

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - Present
  • OH State Medical License
    OH State Medical License 1993 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

  • Fellow (FHRS) Heart Rhythm Society
  • Fellow (FAHA) American Heart Association
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic  
    Hanad Bashir, Shameer Khubber, Khaled M Sleik, Mina K Chung, Umesh N Khot, Samir R Kapadia, JAMA Network Open
  • Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)  
    Andres E Carmona-Rubio, Miriam Jacob, Gary W Procop, Mina K Chung, JAMA Cardiology
  • His Bundle Pacing  
    Gaurav A Upadhyay, John D Fisher, Pugazhendhi Vijayaraman, Mina K Chung, George Crossley, Byron K Lee, Sanjeev Saksena, Gopi Dandamudi, Kousik Krishnan, ScienceDirect
  • Join now to see all

Lectures

  • Born to Be Bad: How Not to Miss a Clue in Family Member of Patient With SCD 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Connected and Wearable Technologies for Arrhythmia Management and Detection 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Pathogenesis of Sarcoidosis - What's Known? - Translational Talk 
    2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Other

Authored Content

  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
  • Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
  • Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
  • Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
  • Join now to see all

Press Mentions

  • Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative Research
    Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative ResearchOctober 11th, 2022
  • National Institutes of Health Awards Cleveland Clinic $14.2 Million Grant to Develop New Treatments for Atrial Fibrillation
    National Institutes of Health Awards Cleveland Clinic $14.2 Million Grant to Develop New Treatments for Atrial FibrillationJuly 1st, 2022
  • Dr. Haqqani: New Research Begins on Afib Recurrence
    Dr. Haqqani: New Research Begins on Afib RecurrenceAugust 2nd, 2021
  • Join now to see all

Committees

  • member, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

Professional Memberships